AMAna Martínez-Cañavate

Ana Martínez-Cañavate

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Martínez-Cañavate has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exposome‐driven molecular sensitization signatures in pediatric rhinitis and asthma across Spanish regions

    by Montserrat Álvaro‐Lozano, Ana María Martínez‐Cañavate, Francisco Carballada, María Mesa‐Del‐Castillo, José Ángel Porto Arceo, Carlos García Magán, Cristina Blasco Valero, Jaime Lozano Blasco, Julián Andrés Manrique Niño, Guillermo Urios Pastor, et al.

    Background: Allergic rhinitis and asthma in childhood arise from dynamic interactions between genetic predisposition and the exposome. However, how environmental heterogeneity shapes molecular IgE sensitization profiles during early life remains insufficiently characterized. Methods: We conducted a prospective, observational, multicentre, cross‐sectional study including 354 children (0–15 years) with allergic rhinitis and/or asthma recruited across eight Spanish cities contrasting regional climatic contexts. All patients were skin prick test‐positive to at least one aeroallergen and underwent multiplex component‐resolved diagnostics using the ALEX platform. Sensitization patterns were analyzed, and unsupervised approaches were applied to identify molecular signatures. Results: Molecular IgE profiling revealed a structured sensitization landscape, with 97.5% of children exhibiting reactivity to at least one allergen. A dominant mite‐related pattern and partially distinct pollen‐ and epithelial‐related patterns were observed. PCA identified composite molecular sensitization gradients and descriptive differences in participant distributions across recruitment centres, although substantial overlap was observed between centres. Age‐stratified analyses identified a non‐linear trajectory of sensitization, characterized by early molecular priming in high‐exposure environments, followed by a marked expansion of IgE levels and allergen sensitization during school age. Rhinitis severity was strongly associated with a denser mite sensitization network. In contrast, asthma severity was driven not by mite sensitization alone but by a complex pollen‐related polysensitization. Conclusion: Pediatric IgE sensitization is structured into molecular patterns associated with geography and age, consistent with a role for environmental context in early allergic trajectories. image

  • Open Access

    Global assessment of the knowledge and confidence in managing allergic disorders amongst primary care paediatricians across Europe: An EAACI Task Force Report.

    by Martha Cabrera, D Ryan, Michel Erlewyn-Lajeunesse, Michael Levin, Ana Martínez-Cañavate, Villaizán Pérez Carmen, Elizabeth Angier, Juan Trujillo, Jm. Cárdenas-Rebollo, Reali L

    Background Paediatricians are often the first point of contact for children in Primary Care (PC), but still perceive gaps in their allergy knowledge. We investigated self-perceived knowledge gaps and educational needs in paediatricians across healthcare systems in Europe so that future educational initiatives may better support the delivery of allergy services in PC. Methods A multinational survey was circulated to paediatricians who care for children and adolescents with allergy problems in PC by the EAACI Allergy Educational Needs in Primary Care Paediatricians Task Force during February to March 2023. A 5-point Likert scale was used to assess level of agreement with questionnaire statements. 30 surveys per country was the cut-off for inclusion and statistical analysis. Results 1,991 respondents were obtained from 56 countries across Europe and 210 responses were from countries with a cut-off below 30 participants per country. Primary care paediatricians (PCPs) comprised 74.4% of the respondents. The majority (65.3%) were contracted to state or district health services. 61.7% had awareness of guidelines for onward allergy referral in their countries but only 22.3% were aware of the EAACI competencies document for allied health professionals for allergy. Total sample respondents versus PCP’s showed 52% and 47% of them have access to allergy investigations in their PC facility (mainly specific IgE and skin prick tests); 67.6% and 58.9% have access to immunotherapy, respectively. The main barrier for referral to a specialist was consideration that the patient’s condition could be diagnosed and treated in this PC facility, (57.8% and 63.6% respectively). The main reasons for referral was the need for hospital assessment, and partial response to first line treatment (55.4% and 59.2%, 47% and 50.7%, respectively). Learning and assessment methods preference was fairly equally divided between: Traditional methods (45.7% and 50.1% respectively) and e-Learning 45.5% and 44.9%, respectively. Generalist Physicians (GP’s) have the poorest access to allergy investigations (32.7%, p=0.000). The majority of the total sample (91.9%) assess patients with allergic pathology. 868 (43.6%) and 1,117 (46.1%), received allergy training as undergraduates and postgraduates respectively [these proportions in PCPs were higher (45% and 59%), respectively]. PCPs with special interest in allergology experienced greater exposure to allergy teaching as postgraduates. GP’s received the largest amount of allergy teaching as undergraduate. Identifying allergic disease based on clinical presentation, respondents felt most confident in the management of eczema/atopic dermatitis (87.4%) and rhinitis/asthma (86.2%), and least confident in allergen immunotherapy (36.9%) and latex allergy (30.8%). Conclusion This study exploring the confidence of PCP’s to diagnose, manage and refer patients with allergy, demonstrated knowledge gaps and educational needs for allergy clinical practice. It detects areas in need of urgent improvement especially in latex and allergen immunotherapy. It is important to ensure dissemination of allergy guidelines and supporting EAACI documents since the majority of PCPs lack awareness of them. This survey has enabled us to identify what the educational priorities of PCPs are and how they would like to have them met.

  • Global assessment of the knowledge and confidence in managing allergic disorders among primary care pediatricians across Europe: An EAACI task force report

    by M. Cabrera, D. Ryan, M. Erlewyn‐Lajeunesse, M. Levin, A. Martínez‐Cañavate, C. Villaizán Pérez, E. Angier, J. Trujillo, J. M. Cárdenas‐Rebollo, L. Reali

    Background: Pediatricians are often the first point of contact for children in Primary Care (PC), but still perceive gaps in their allergy knowledge. We investigated self‐perceived knowledge gaps and educational needs in pediatricians across healthcare systems in Europe so that future educational initiatives may better support the delivery of allergy services in PC.Method: A multinational survey was circulated to pediatricians who care for children and adolescents with allergy problems in PC by the EAACI Allergy Educational Needs in Primary Care Pediatricians Task Force from February to March 2023. A 5‐point Likert scale was used to assess the level of agreement with questionnaire statements. Thirty surveys per country were the cut‐off for inclusion and statistical analysis.Results: In this study, 1991 respondents were obtained from 56 countries across Europe and 210 responses were from countries with a cut‐off below 30 participants per country. Primary care pediatricians (PCPs) comprised 74.4% of the respondents. The majority (65.3%) were contracted to state or district health services. 61.7% had awareness of guidelines for onward allergy referral in their countries but only 22.3% were aware of the EAACI competencies document for allied health professionals for allergy. Total sample respondents versus PCPs showed 52% and 47% of them have access to allergy investigations in their PC facility (mainly specific IgE and skin prick tests); 67.6% and 58.9% have access to immunotherapy, respectively. The main barrier to referral to a specialist was a consideration that the patient's condition could be diagnosed and treated in this PC facility, (57.8% and 63.6% respectively). The main reasons for referral were the need for hospital assessment, and partial response to first‐line treatment (55.4% and 59.2%, 47% and 50.7%, respectively). Learning and assessment methods preference was fairly equally divided between Traditional methods (45.7% and 50.1% respectively) and e‐learning 45.5% and 44.9%, respectively. Generalist physicians (GPs) have the poorest access to allergy investigations (32.7%, p = .000). The majority of the total sample (91.9%) assess patients with allergic pathology. 868 (43.6%) and 1117 (46.1%), received allergy training as undergraduates and postgraduates respectively [these proportions in PCPs were higher (45% and 59%), respectively]. PCPs with a special interest in allergology experienced greater exposure to allergy teaching as postgraduates. GPs received the largest amount of allergy teaching as undergraduates. Identifying allergic disease based on clinical presentation, respondents felt most confident in the management of eczema/atopic dermatitis (87.4%) and rhinitis/asthma (86.2%), and least confident in allergen immunotherapy (36.9%) and latex allergy (30.8%).Conclusion: This study exploring the confidence of PCPs to diagnose, manage, and refer patients with allergies, demonstrated knowledge gaps and educational needs for allergy clinical practice. It detects areas in need of urgent improvement especially in latex and allergen immunotherapy. It is important to ensure the dissemination of allergy guidelines and supporting EAACI documents since the majority of PCPs lack awareness of them. This survey has enabled us to identify what the educational priorities of PCPs are and how they would like to have them met.


  • Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disorders

    by Martha Cabrera, Dermot Ryan, Michel Erlewyn‐Lajeunesse, Michael Eliad Levin, Ana Martínez‐Cañavate, Carmen Villaizán Pérez, Elizabeth Angier, Juan Trujillo, José Miguel Cárdenas‐Rebollo, Laura Losappio, et al.


  • Open Access

    Alergia a metilprednisolona

    by Ana Josefa Pérez-Aragón, Manuel Díaz-Molina, María Teresa Romero-Paniagua, Ana Martínez-Cañavate

    Corticosteroids are drugs widely used in medical practice due to their potent anti-inflammatory and immunomodulatory effect. Although most of the adverse reactions are well known, allergic reactions are uncommon. Hydrocortisone and methylprednisolone are the most commonly implicated drugs. An estimated 0.3% incidence of allergic reactions, some of them severe, has been estimated, so the possibility of their occurrence should be considered when these medications are used.